RGLS logo

Regulus Therapeutics (RGLS) Total Assets

Annual Total Assets

$30.75 M
-$15.97 M-34.18%

31 December 2023

RGLS Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$93.76 M
-$10.36 M-9.95%

30 September 2024

RGLS Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RGLS Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-34.2%+148.4%
3 y3 years-18.2%+117.8%
5 y5 years+10.1%+337.9%

RGLS Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-55.1%at low-17.9%+204.9%
5 y5 years-55.1%+10.1%-17.9%+337.9%
alltimeall time-82.1%+10.1%-45.3%+371.7%

Regulus Therapeutics Total Assets History

DateAnnualQuarterly
Sept 2024
-
$93.76 M(-9.9%)
June 2024
-
$104.12 M(-8.8%)
Mar 2024
-
$114.14 M(+271.2%)
Dec 2023
$30.75 M(-34.2%)
$30.75 M(-18.5%)
Sept 2023
-
$37.75 M(-13.5%)
June 2023
-
$43.65 M(+17.9%)
Mar 2023
-
$37.02 M(-20.8%)
Dec 2022
$46.72 M(-31.8%)
$46.72 M(-10.4%)
Sept 2022
-
$52.13 M(-4.0%)
June 2022
-
$54.30 M(-11.0%)
Mar 2022
-
$60.98 M(-10.9%)
Dec 2021
$68.45 M(+82.0%)
$68.45 M(+59.0%)
Sept 2021
-
$43.04 M(-13.1%)
June 2021
-
$49.52 M(+24.3%)
Mar 2021
-
$39.84 M(+5.9%)
Dec 2020
$37.60 M(-10.6%)
$37.60 M(+37.5%)
Sept 2020
-
$27.34 M(-8.2%)
June 2020
-
$29.78 M(-14.9%)
Mar 2020
-
$35.01 M(-16.8%)
Dec 2019
$42.08 M(+50.7%)
$42.08 M(+96.5%)
Sept 2019
-
$21.41 M(-16.7%)
June 2019
-
$25.69 M(+29.2%)
Mar 2019
-
$19.88 M(-28.8%)
Dec 2018
$27.93 M
$27.93 M(-19.7%)
Sept 2018
-
$34.77 M(-29.3%)
DateAnnualQuarterly
June 2018
-
$49.17 M(-20.8%)
Mar 2018
-
$62.08 M(-20.2%)
Dec 2017
$77.81 M(-22.7%)
$77.81 M(-14.4%)
Sept 2017
-
$90.85 M(+46.9%)
June 2017
-
$61.86 M(-22.8%)
Mar 2017
-
$80.17 M(-20.4%)
Dec 2016
$100.66 M(-28.7%)
$100.66 M(-13.4%)
Sept 2016
-
$116.27 M(-10.5%)
June 2016
-
$129.93 M(+1.4%)
Mar 2016
-
$128.14 M(-9.2%)
Dec 2015
$141.08 M(-17.7%)
$141.08 M(-1.6%)
Sept 2015
-
$143.45 M(-4.5%)
June 2015
-
$150.26 M(-8.8%)
Mar 2015
-
$164.85 M(-3.9%)
Dec 2014
$171.48 M(+39.3%)
$171.48 M(+64.9%)
Sept 2014
-
$104.02 M(-8.7%)
June 2014
-
$113.92 M(-8.2%)
Mar 2014
-
$124.11 M(+0.8%)
Dec 2013
$123.06 M(+18.9%)
$123.06 M(-5.8%)
Sept 2013
-
$130.59 M(+41.2%)
June 2013
-
$92.52 M(-4.6%)
Mar 2013
-
$97.03 M(-6.3%)
Dec 2012
$103.52 M(+141.4%)
$103.52 M(+154.2%)
Sept 2012
-
$40.72 M(+22.7%)
June 2012
-
$33.19 M(-22.6%)
Dec 2011
$42.88 M
$42.88 M

FAQ

  • What is Regulus Therapeutics annual total assets?
  • What is the all time high annual total assets for Regulus Therapeutics?
  • What is Regulus Therapeutics annual total assets year-on-year change?
  • What is Regulus Therapeutics quarterly total assets?
  • What is the all time high quarterly total assets for Regulus Therapeutics?
  • What is Regulus Therapeutics quarterly total assets year-on-year change?

What is Regulus Therapeutics annual total assets?

The current annual total assets of RGLS is $30.75 M

What is the all time high annual total assets for Regulus Therapeutics?

Regulus Therapeutics all-time high annual total assets is $171.48 M

What is Regulus Therapeutics annual total assets year-on-year change?

Over the past year, RGLS annual total assets has changed by -$15.97 M (-34.18%)

What is Regulus Therapeutics quarterly total assets?

The current quarterly total assets of RGLS is $93.76 M

What is the all time high quarterly total assets for Regulus Therapeutics?

Regulus Therapeutics all-time high quarterly total assets is $171.48 M

What is Regulus Therapeutics quarterly total assets year-on-year change?

Over the past year, RGLS quarterly total assets has changed by +$56.02 M (+148.40%)